Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis

Background. Preexposure prophylaxis (PrEP) with emtricitabine plus tenofovir disoproxil fumarate (FTC/TDF) or TDF alone reduces the risk of human immunodeficiency virus (HIV) acquisition. Understanding the risk of antiretroviral resistance selected by PrEP during breakthrough infections is important...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Infect Dis
المؤلفون الرئيسيون: Lehman, Dara A., Baeten, Jared M., McCoy, Connor O., Weis, Julie F., Peterson, Dylan, Mbara, Gerald, Donnell, Deborah, Thomas, Katherine K., Hendrix, Craig W., Marzinke, Mark A., Frenkel, Lisa, Ndase, Patrick, Mugo, Nelly R., Celum, Connie, Overbaugh, Julie, Matsen, Frederick A., Coombs, Robert W., Lingappa, Jairam, McElrath, M. Juliana, Fife, Kenneth, Were, Edwin, Tumwesigye, Elioda, Katabira, Elly, Ronald, Allan, Bukusi, Elizabeth, Cohen, Craig, Wangisi, Jonathan, Campbell, James, Tappero, Jordan, Kiarie, James, Farquhar, Carey, John-Stewart, Grace, Mugo, Nelly Rwamba
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2015
الموضوعات:
Major Articles and Brief Reports
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402339/
https://ncbi.nlm.nih.gov/pubmed/25587020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu677
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة